Movement disorders in psychiatric patients

被引:16
作者
Perju-Dumbrava, Laura [1 ]
Kempster, Peter [1 ,2 ]
机构
[1] Monash Med Ctr Clayton, Neurosci, Clayton, Vic, Australia
[2] Monash Univ, Sch Clin Sci Med, Clayton, Vic, Australia
关键词
movement disorders; psychiatry; schizophrenia; NEUROLEPTIC MALIGNANT SYNDROME; TARDIVE-DYSKINESIA; DOPAMINE HYPOTHESIS; SCHIZOPHRENIA; PARKINSONISM; PREVALENCE; CATATONIA; TETRABENAZINE; PROGRESSION; POPULATION;
D O I
10.1136/bmjno-2020-000057
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The observability of movement gives it advantages when trying to draw connections between brain and mind. Disturbed motor function pervades schizophrenia, though it is difficult now to subtract the effects of antipsychotic treatment. There is evidence from patients never exposed to these drugs that dyskinesia and even parkinsonism are to some degree innate to schizophrenia. Tardive dyskinesia and drug-induced parkinsonism are the most common movement disorders encountered in psychiatric practice. While D2 dopamine receptor blockade is a causative factor, both conditions defy straightforward neurochemical explanation. Balanced against the need to manage schizophrenic symptoms, neither prevention nor treatment is easy. Of all disorders classified as psychiatric, catatonia sits closest to organic neurology on the neuropsychiatric spectrum. Not only does it occur in the setting of unequivocally organic cerebral disease, but the alterations of consciousness it produces have 'organic' qualities even when the cause is psychiatric. No longer considered a subtype of schizophrenia, catatonia is defined by syndromic features based on motor phenomenology. Both severe depression and obsessive-compulsive disorder may be associated with 'soft' extrapyramidal signs that resemble parkinsonian bradykinesia. As functional neuroimaging studies suggest, movement and psychiatric disorders involve the same network connections between the basal ganglia and the cerebral cortex.
引用
收藏
页数:7
相关论文
共 57 条
  • [1] Posture-Motor and Posture-Ideomotor Dual-Tasking: A Putative Marker of Psychomotor Retardation and Depressive Rumination in Patients With Major Depressive Disorder
    Aftanas, Lyubomir I.
    Bazanova, Olga M.
    Novozhilova, Nataliya V.
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2018, 12
  • [2] American Psychiatric A, 2013, DIAGN STAT MAN MENT, P1, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]
  • [3] [Anonymous], 1971, Dementia praecox and paraphrenia
  • [4] A SURVEY OF DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS
    AYD, FJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 175 (12): : 1054 - &
  • [5] Dramatic improvement of tardive dyskinesia movements by inline skating
    Barbosa Casagrande, Sara Carvalho
    Cury, Rubens Gisbert
    de Lima-Pardini, Andrea Cristina
    Coelho, Daniel Boari
    Souza, Carolina de Oliveira
    dos Santos Ghilardi, Maria Gabriela
    Silveira-Moriyama, Laura
    Teixeira, Luis Augusto
    Barbosa, Egberto Reis
    Fonoff, Erich Talamoni
    [J]. NEUROLOGY, 2017, 89 (02) : 211 - 213
  • [6] Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm
    Bhidayasiri, Roongroj
    Jitkritsadakul, Onanong
    Friedman, Joseph H.
    Fahn, Stanley
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 389 : 67 - 75
  • [7] The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue
    Brisch, Ralf
    Saniotis, Arthur
    Wolf, Rainer
    Bielau, Hendrik
    Bernstein, Hans-Gert
    Steiner, Johann
    Bogerts, Bernhard
    Braun, Katharina
    Jankowski, Zbigniew
    Kumaratilake, Jaliya
    Henneberg, Maciej
    Gos, Tomasz
    [J]. FRONTIERS IN PSYCHIATRY, 2014, 5
  • [8] Burkhard Pierre R, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS108, DOI 10.1016/S1353-8020(13)70027-0
  • [9] Catatonia .1. Rating scale and standardized examination
    Bush, G
    Fink, M
    Petrides, G
    Dowling, F
    Francis, A
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1996, 93 (02) : 129 - 136
  • [10] CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140